SCHEMBL5259003

SCHEMBL5259003

Cn1cc(C(c2ccccc2)N2CCCCC2)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
IDO1 P14902 1/20 0.46
CYP2D6 P10635 6/20 0.45
KCNH2 Q12809 6/20 0.45
CHRM2 P08172 2/20 0.45
ADRA2A P08913 2/20 0.45
CHRM1 P11229 2/20 0.45
DRD1 P21728 2/20 0.45
OPRM1 P35372 2/20 0.45
DRD3 P35462 2/20 0.45
SLC6A3 Q01959 2/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CHRM3 P20309 1/20 0.45
ADRA1D P25100 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5257318 0.86 HSP90AA1 (0.54) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL5263837 0.80 L3MBTL1 (0.48) L3MBTL1KMT2AMEN1POLBIDO1
SCHEMBL24302803 0.77 L3MBTL1 (0.51) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL27493155 0.77 L3MBTL1 (0.61) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL27960948 0.75 MEN1 (0.59) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL24302812 0.74 IDO1 (0.60) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL5267415 0.74 CYP2D6 (0.68) L3MBTL1KMT2AMEN1CYP2D6KCNH2
SCHEMBL27983751 0.73 MEN1 (0.56) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL16154384 0.73 MEN1 (0.60) L3MBTL1KMT2AMEN1NPC1POLB
SCHEMBL477500 0.72 IDO1 (0.61) L3MBTL1KMT2AMEN1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261585-B1 SUBSTITUTED INDOLE MANNICH BASES GRUENENTHAL GMBH (DE) 2007-09-26 EP claimed
EP-1261585-B1 SUBSTITUTED INDOLE MANNICH BASES GRUENENTHAL GMBH (DE) 2007-09-26 EP disclosed
EP-1261585-B1 SUBSTITUTED INDOLE MANNICH BASES GRUENENTHAL GMBH (DE) 2007-09-26 EP disclosed
US-7091220-B2 Substituted indole Mannich bases GRUENENTHAL GMBH (DE) 2006-08-15 US disclosed
US-20030060497-A1 Subtituted indole mannich bases GRUENENTHAL GMBH (DE) 2003-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060497-A1 Subtituted indole mannich bases TPH1, IDO1, TPH2 L3MBTL1 2086/4885KMT2A 2274/4885MEN1 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.